$807.71
-7.08-0.87%
가까이에: Aug 26, 5:00 PM EST
$807.71
-7.08-0.87%
프리마켓: 7:17 AM EST
Benzinga
Benzinga
Benzinga
금요일, 8월 28
Regeneron Pharmaceuticals Inc
REGNNASDAQ
Regeneron Pharmaceuticals Earnings & Forecasts
Regeneron Pharmaceuticals (REGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Regeneron Pharmaceuticals Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $10.34 | $8.38 | $9.69 | $8.84 |
| Actual | $14.29 | $9.47 | $11.44 | $11.83 |
| Surprise | +38.2% | +13.0% | +18.1% | +33.8% |
| Revenue | ||||
| Estimate | $3.81B | $3.47B | $3.80B | $3.59B |
| Actual | $4.29B | $3.60B | $3.88B | $3.75B |
| Surprise | +12.5% | +3.75% | +2.27% | +4.47% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $15.38 | $15.03 | $9.49 | $11.06 |
| Revenue | ||||
| Consensus | $4.52B | $4.60B | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved